Protected: Lessons Learned from Cataract Surgery

Terminating the Physician-Patient Relationship

Terminating the Physician-Patient Relationship Updated

Giant Cell Arteritis: Delayed diagnosis and treatment

August 17, 2022

Dear OMIC Insureds:

OMIC is pleased to announce the release of our newest Digest:

Giant Cell Arteritis: Delayed diagnosis and treatment

• Highlights recent claims data, explores new case studies, and offers risk management recommendations
• Gives you links to practical GCA risk management tools:
• Updated GCA Checklist
• New GCA Patient Information Sheet with Consent to/Refusal of Treatment
• Includes news from OMIC’s Chair, Dan Briceland, MD
• Provides updated information about liability and coverage issues related to patient falls

If you have questions, contact us for confidential risk management advice at riskmanagement@omic.com. Or call us at 1-800-562-6642, enter 4 for Risk Management.

Sincerely,

Jane Mock, CPHRM
OMIC Risk Manager

______________________________________________

Giant Cell Arteritis Risk Management Recommendations (2022)

Giant Cell Arteritis_2022

OMIC Digest Archives 2022

	OMIC Digest: Vol. 32 | No. 1 | 2022 Feature: Giant Cell Arteritis: Delayed diagnosis and treatment Eye on OMIC: Board changes and a new Chair announced for 2023 Policy Issues: Liability and coverage for patient falls Closed Claim Study: Failure to diagnose Giant Cell Arteritis results in settlement Risk Management Remedies: What’s in your toolbox? < click to view or download